![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: L3MBTL4 |
Gene summary for L3MBTL4 |
![]() |
Gene information | Species | Human | Gene symbol | L3MBTL4 | Gene ID | 91133 |
Gene name | L3MBTL histone methyl-lysine binding protein 4 | |
Gene Alias | HsT1031 | |
Cytomap | 18p11.31 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | F8W9S8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
91133 | L3MBTL4 | Pt14.d | Human | Liver | HCC | 5.16e-09 | -3.13e-01 | 0.0143 |
91133 | L3MBTL4 | S014 | Human | Liver | HCC | 4.65e-07 | 2.00e-01 | 0.2254 |
91133 | L3MBTL4 | S015 | Human | Liver | HCC | 9.81e-08 | 5.05e-01 | 0.2375 |
91133 | L3MBTL4 | S016 | Human | Liver | HCC | 6.58e-05 | 2.09e-01 | 0.2243 |
91133 | L3MBTL4 | S028 | Human | Liver | HCC | 4.69e-03 | 2.04e-02 | 0.2503 |
91133 | L3MBTL4 | RNA-P10T1-P10T1-2 | Human | Lung | AIS | 2.49e-02 | 7.44e-01 | -0.1028 |
91133 | L3MBTL4 | RNA-P10T2-P10T2-3 | Human | Lung | AAH | 1.22e-02 | 5.52e-01 | -0.1408 |
91133 | L3MBTL4 | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.48e-03 | 4.21e-01 | 0.3385 |
91133 | L3MBTL4 | RNA-P17T-P17T-8 | Human | Lung | IAC | 1.55e-04 | 4.85e-01 | 0.3329 |
91133 | L3MBTL4 | RNA-P18T-P18T-4 | Human | Lung | IAC | 1.16e-02 | 9.14e-01 | 0.1024 |
91133 | L3MBTL4 | RNA-P18T-P18T-8 | Human | Lung | IAC | 7.36e-03 | 7.80e-01 | 0.1151 |
91133 | L3MBTL4 | RNA-P23T2-P23T2-1 | Human | Lung | MIAC | 5.30e-08 | 1.15e+00 | -0.037 |
91133 | L3MBTL4 | RNA-P23T2-P23T2-2 | Human | Lung | MIAC | 4.97e-07 | 8.50e-01 | -0.028 |
91133 | L3MBTL4 | RNA-P23T2-P23T2-4 | Human | Lung | MIAC | 1.25e-08 | 1.28e+00 | -0.0272 |
91133 | L3MBTL4 | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 3.89e-21 | 8.22e-01 | -0.2116 |
91133 | L3MBTL4 | RNA-P25T1-P25T1-2 | Human | Lung | AIS | 6.92e-13 | 9.04e-01 | -0.1941 |
91133 | L3MBTL4 | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 5.94e-12 | 8.04e-01 | -0.2107 |
91133 | L3MBTL4 | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 7.79e-21 | 8.82e-01 | -0.2119 |
91133 | L3MBTL4 | RNA-P3T-P3T-1 | Human | Lung | IAC | 8.87e-03 | 3.11e-01 | 0.1829 |
91133 | L3MBTL4 | RNA-P6T1-P6T1-4 | Human | Lung | MIAC | 5.54e-03 | 4.55e-01 | -0.0263 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006325 | Colorectum | AD | chromatin organization | 119/3918 | 409/18723 | 4.85e-05 | 8.33e-04 | 119 |
GO:00063251 | Colorectum | SER | chromatin organization | 89/2897 | 409/18723 | 4.15e-04 | 6.17e-03 | 89 |
GO:00063252 | Colorectum | MSS | chromatin organization | 107/3467 | 409/18723 | 7.22e-05 | 1.21e-03 | 107 |
GO:00063253 | Colorectum | FAP | chromatin organization | 84/2622 | 409/18723 | 1.62e-04 | 2.47e-03 | 84 |
GO:00063254 | Colorectum | CRC | chromatin organization | 74/2078 | 409/18723 | 1.48e-05 | 4.61e-04 | 74 |
GO:00063258 | Endometrium | AEH | chromatin organization | 64/2100 | 409/18723 | 3.69e-03 | 2.52e-02 | 64 |
GO:000632513 | Endometrium | EEC | chromatin organization | 65/2168 | 409/18723 | 4.98e-03 | 3.14e-02 | 65 |
GO:00063255 | Liver | NAFLD | chromatin organization | 64/1882 | 409/18723 | 2.31e-04 | 3.89e-03 | 64 |
GO:000632511 | Liver | HCC | chromatin organization | 206/7958 | 409/18723 | 7.23e-04 | 4.41e-03 | 206 |
GO:00063256 | Lung | IAC | chromatin organization | 69/2061 | 409/18723 | 2.01e-04 | 3.53e-03 | 69 |
GO:000632512 | Lung | AIS | chromatin organization | 62/1849 | 409/18723 | 4.24e-04 | 7.29e-03 | 62 |
GO:00063259 | Prostate | BPH | chromatin organization | 101/3107 | 409/18723 | 1.52e-05 | 1.94e-04 | 101 |
GO:000632518 | Skin | AK | chromatin organization | 73/1910 | 409/18723 | 1.40e-06 | 4.26e-05 | 73 |
GO:000632519 | Skin | cSCC | chromatin organization | 147/4864 | 409/18723 | 4.41e-06 | 6.52e-05 | 147 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
L3MBTL4 | SNV | Missense_Mutation | novel | c.1483N>C | p.Glu495Gln | p.E495Q | Q8NA19 | protein_coding | tolerated(0.52) | benign(0.036) | TCGA-5L-AAT1-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | letrozol | SD |
L3MBTL4 | SNV | Missense_Mutation | rs777736801 | c.1060N>G | p.Cys354Gly | p.C354G | Q8NA19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A2-A0CS-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD |
L3MBTL4 | SNV | Missense_Mutation | rs777736801 | c.1060N>G | p.Cys354Gly | p.C354G | Q8NA19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A7-A26G-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
L3MBTL4 | SNV | Missense_Mutation | rs376926845 | c.1259G>A | p.Arg420His | p.R420H | Q8NA19 | protein_coding | deleterious(0.02) | probably_damaging(0.981) | TCGA-A8-A09W-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
L3MBTL4 | SNV | Missense_Mutation | c.108N>G | p.Ser36Arg | p.S36R | Q8NA19 | protein_coding | tolerated(0.44) | benign(0.003) | TCGA-AN-A0AM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
L3MBTL4 | SNV | Missense_Mutation | rs777736801 | c.1060N>G | p.Cys354Gly | p.C354G | Q8NA19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B6-A1KI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
L3MBTL4 | SNV | Missense_Mutation | rs777736801 | c.1060N>G | p.Cys354Gly | p.C354G | Q8NA19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C8-A273-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
L3MBTL4 | SNV | Missense_Mutation | rs777736801 | c.1060N>G | p.Cys354Gly | p.C354G | Q8NA19 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A1X6-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | SD |
L3MBTL4 | SNV | Missense_Mutation | rs762517126 | c.1565N>A | p.Arg522Lys | p.R522K | Q8NA19 | protein_coding | tolerated(0.05) | possibly_damaging(0.593) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
L3MBTL4 | SNV | Missense_Mutation | novel | c.1840N>A | p.Asp614Asn | p.D614N | Q8NA19 | protein_coding | deleterious_low_confidence(0.04) | possibly_damaging(0.831) | TCGA-LD-A7W6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | letrozole | SD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |